Pre-implantation Genetic Diagnosis: an overview and recent advances..

1. Pre-implantation Genetic Testing - Learn Genetics Pre-implantation Genetic Diagnosis (PGD or PIGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization. PGD is considered in a similar fashion to prenatal diagnosis. When used to screen for a specific genetic disease, its main advantage is that it avoids selective abortion, as the method makes it highly likely that the baby will be free of the disease under consideration. PGD thus is an adjunct to assisted reproductive technology, and requires in vitro fertilization (IVF) to obtain oocytes or embryos for evaluation. Embryos are generally obtained through blast mere or blastocyst biopsy. The latter technique has proved to be less deleterious for the embryo, therefore it is advisable to perform the biopsy around day 5 or 6 of development. The world's first PGD was performed by Handy side , Kontogianni and Winston at the Hammersmith Hospital in London. Female embryos were selectively transferred in five couples at risk of X-linked disease, resulting in two twins and one singleton pregnancy. Trends in Pre-implantation Genetic Testing Global pre-implantation genetic testing market is predicted to achieve USD 465.1 million by 2026 at a CAGR of 8.7% during the forecast period of 2019–2026. Segmental Insights Trends

2. Pre-implantation Genetic Diagnosis Market is segmented by Procedure Type, Application and Technology. By Procedure Type Pre-implantation Genetic Screening Pre-implantation Genetic Diagnosis On the basis of Technology :- Next-Generation Sequencing, Polymerase Chain Reaction. By Application Aneuploidy Screening Single Gene Disorder Screening A genetic test is an study of our DNA, genetic material in our cells, that gives us specific characteristics and enables our body to perform various functions. A number of different methods exist for fast and reliable testing of our DNA, with sequencing and cancellation/duplication study being the most common. Sometimes, biochemical/biomarker testing allows an early diagnosis and continuous therapy monitoring, especially in the field of lysosome storage disorders. Regional Insights: Global pre-implantation genetic testing market is segmented by the Americas, Asia Pacific, Europe, and the Middle East and Africa. • North America • Europe • Asia Pacific • The Middle East & Africa Competitive Landscape: Some of the key players in the pre-implantation genetic testing market are Illumina Inc , SciGene Corporation, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Yikon Genomics, Oxford Gene Technology, Rubicon Genomics Inc etc. Get FREE Sample copy of Pre-implantation Genetic Testing Market @ https://straitsresearch.com/report/preimplantation-genetic-testing-market/request-sample About StraitsResearch: StraitsResearch, we have a tendency to alter our buyers to solve the quality of assorted industries through our marketing research & Consulting Services.

3. Our reports area unit single-point solutions for businesses to grow, evolve, and mature. Our period information assortment strategies in conjunction with ability to trace quite a million high growth niche merchandise area unit aligned together with your aims. The elaborated and proprietary applied mathematics models employed by our analysts supply insights for creating right call within the shortest span of your time. For organizations that need specific however comprehensive data we provide tailor-made solutions through adhoc reports. These requests area unit delivered with the right combination of right sense of fact-oriented downside finding methodologies and investment existing information repositories. Contact: Straits Research 825 3rd Avenue, New York, NY 10022. Phone Number :- +1 6464807505. Email : sales@straitsresearch.com. Website : https://straitsresearch.com/